Article
Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes.
Acta neuropathologica - 1 Feb 2014
Stieber Daniel, Golebiewska Anna, Evers Lisa, Lenkiewicz Elizabeth, Brons Nicolaas H C, Nicot Nathalie, Oudin Anaïs, Bougnaud Sébastien, Hertel Frank, Bjerkvig Rolf, Vallar Laurent, Barrett Michael T, Niclou Simone P
Abstract excerpt
Glioblastoma (GBM) is known to be a heterogeneous disease; however, the genetic composition of the cells within a given tumour is only poorly explored. In the advent of personalised medicine the understanding of intra-tumoural heterogeneity at the cellular and the genetic level is mandatory to improve treatment and clinical outcome. By combining ploidy-based flow sorting with array-comparative genomic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
